Skip to main content
Buprenorphine, methadone, naltrexone may benefit teens with opioid use disorder

A review in the Journal of Studies on Alcohol and Drugs associated buprenorphine to increased odds of treatment retention and opioid abstinence among adolescents with opioid use disorder, while methadone was tied to maintained treatment among those with heroin use disorder. Emerging data also showed the safety and feasibility of naltrexone for youths with OUD.

Full Story: